First-in-human phase I/IIa study investigating inhaled CIS-DPI as add-on treatment in Stage IV NSCLC patients

Status

Completed

Phases

Phase 1Phase 2

Study type

Interventional

Source

EU CTIS

Registry ID

CTIS2022-501183-17-00

Acronym

CIS-DPI-01

Enrollment

Registered

2022-12-06

Start date

2023-02-23

Completion date

2025-10-29

Last updated

2025-07-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Non-Small Cell Lung Cancer

None listed

Sex/Gender

All

Age

18 Years to No maximum

Belgium, France, Spain

None listed

Source: EU CTIS · Data processed: Feb 4, 2026